Related Experiment Video

Updated: Dec 17, 2025

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

4.9K

Activation of glycogenolysis and glycolysis in breast cancer stem cell models

Etna Abad1, Sara Samino2, Oscar Yanes3

  • 1Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
|June 28, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Breast cancerCancer stem cellGlycogenolysisGlycolysisHIF1aMetabolic reprogramming

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.0K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.1K

Related Experiment Videos

Last Updated: Dec 17, 2025

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

4.9K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.0K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.1K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K

Articles linked to this work by shared authors, journal, and citation graph.

Protein damage and repair in aging: Mechanisms, homeostasis and disease.

Ageing research reviews·2026

POMC AMPKα1 deletion drives male-specific BAT thermogenesis and obesity resistance.

EMBO reports·2026

Particles of echovirus 18 open to release their genomes in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2026

Nuclear adenosine metabolism defines a metabolic vulnerability unmasked by TP53 loss.

bioRxiv : the preprint server for biology·2026

Cardiovascular risk and metabolomic profile in adolescents: A comparative study between anorexia nervosa, normal weight, and obesity.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026

Plasma-Derived Extracellular Vesicle-Enriched Fractions as a Potential Source of Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): A Shotgun Proteomic Exploration Analysis.

Diagnostics (Basel, Switzerland)·2026

LGR4 interacts with RhoA to modulate cell survival and epithelial-mesenchymal transition via the Wnt/β-catenin pathway in benign prostatic hyperplasia.

Biochimica et biophysica acta. Molecular basis of disease·2026

Nav1.3 inhibition confers neuroprotection in traumatic brain injury by attenuating neuroinflammation and neuronal cell death via NCOA4-associated ferritin turnover.

Biochimica et biophysica acta. Molecular basis of disease·2026

USF1 promotes growth and glycolysis in acute myeloid leukemia cells.

Biochimica et biophysica acta. Molecular basis of disease·2026

Role of HIF1α in FXR-mediated protection and anti-inflammatory macrophage polarization in parenteral nutrition-associated cholestasis.

Biochimica et biophysica acta. Molecular basis of disease·2026

All-trans retinoic acid-driven immune remodeling in esophageal squamous cell carcinoma revealed by single-cell transcriptomics.

Biochimica et biophysica acta. Molecular basis of disease·2026

A novel NDUFS1 missense variant associated with optic atrophy and mitochondrial dysfunction.

Biochimica et biophysica acta. Molecular basis of disease·2026

Familial Cancers Associated With Cancers of the Breast, Prostate, Colorectum, and Lung in Sweden.

International journal of cancer·2026

The Gut Microbiota-inflammation-immune Axis in Cancer: Anti-inflammatory Mechanisms and Therapeutic Implications.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026

The Association Between CD40 rs1883832 Polymorphism and Cancer Susceptibility: A Systematic Review and Meta-Analysis.

Cancer medicine·2026

Glucose control and clinical outcomes in surgical patients: A narrative review.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026

A health-system-scale, episode-resolved multimodal atlas of cancer cachexia.

Nature medicine·2026

Acne: epidemiology, risk factors, pathogenesis, management and cutting-edge research.

Signal transduction and targeted therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us